Gut–skin axis

The gut–skin axis describes hypothesised and demonstrated links between intestinal biology (microbiota, barrier, immune signalling, diet) and skin health. It is not one mechanism, it is an umbrella for routes that include systemic inflammation, immune cell trafficking, bacterial metabolites, and overlapping genetic and environmental risk.

Stool microbiome reports do not sample skin. A dysbiosis flag in faeces is not a skin microbiome diagnosis.

Hub: Reading your microbiome report. For body-site limits: Stool vs saliva vs blood.


Two microbiomes, two habitats

The Human Microbiome Project and follow-on work show body sites cluster separately, skin, oral, gut, and vaginal communities are not interchangeable (HMP 2012; Rinninella 2019 healthy-gut context).

SiteTypical environmentConsumer test?
Colon (stool)Anaerobic, fermentativeYes, most DTC gut kits
SkinVariable moisture, pH, sebum; distinct taxa (Cutibacterium, Staphylococcus, etc.)Separate skin kits, not this site’s focus
OralDifferent from bothSaliva kits, see Sample types

Practical takeaway: optimising a stool report line does not automatically optimise skin ecology. Cross-talk may exist at the immune and systemic level without taxon parity between sites.


Mechanism routes (where gut pages already help)

RouteGut-side biologyExisting site pages
Mucosal barrier & permeabilityAntigen flux, immune activationIntestinal barrier
Mucosal / systemic immune signallingCytokines, IgA, toleranceGut–immune axis, Secretory IgA
SCFA and metabolite signallingPropionate and butyrate in immune modulation researchSCFAs
Diet and fermentable carbohydratesFODMAP load, fibre, prebiotic trialsFODMAPs, Dietary fiber
Histamine / mast cell overlapGI + skin flushing, urticaria patternsHistamine, MCAS, and food chemicals
IBD-associated skin manifestationsErythema nodosum, pyoderma gangrenosum, clinical IBD firstIBD vs functional gut, Gut inflammation markers

When gut-focused work may be relevant to skin (evidence varies)

Clinical contextGut workup may matter because…Site routing
IBD with skin flaresShared inflammatory diseaseGastroenterology + dermatology, not stool startup kit alone
Coeliac diseaseDermatitis herpetiformisGluten-related disorders, serology/biopsy
Refractory eczema + GI symptomsSelect cases: EoE, coeliac, IBD screenClinical exclusion before microbiome entrepreneurship
Rosacea + SIBO hypothesesWeak/ contested literature; breath testing separateSIBO & breath testing
Isolated acne / mild eczemaDiet trials (low-GI, dairy subsets), modest evidenceDermatology primary; diet pages for GI symptom overlap only

This site does not yet host condition-specific dermatology depth (acne, atopic dermatitis trials). Treat gut report lines as secondary when skin is the main complaint.


What consumer gut reports cannot show for skin

Cannot infer from stool sequencingWhy
Skin microbiome compositionWrong anatomical site
Sebum, pH, or barrier on face/trunkNot measured
Topical treatment responseDermatology management
IgE food allergy causing urticariaAllergy testing, not 16S
Hormonal acneEndocrine evaluation

Symptom overlap routing

If you mainly notice…Start here (gut site scope)Also consider
Skin + bloating/diarrhoeaChronic bloating, FODMAPsDermatologist for rash morphology
Skin flushing + GI urgencyHistamine, MCASSpecialist allergy/immunology
Skin + bloody stools / weight lossRed flagsUrgent GI workup
Skin + fatigue + anaemiaFatigueCoeliac, IBD screen clinically

What not to conclude

Marketing claimReality check
”Heal gut, clear skin” from one dysbiosis scoreNo validated skin endpoint on kits
Stool Lactobacillus ↔ skin LactobacillusDifferent niches; oral probiotics often transient, Lactobacillus species
Low diversity = acne causeDiversity is habitat- and context-specific, Alpha diversity
Eliminate all fermentable carbs for skinMay help GI symptoms; long-term microbiome trade-offs, FODMAPs

Context if you're reading a report

Supplement and probiotic marketing often promises "clear skin from the inside" based on stool dysbiosis lines. Readers need habitat separation (stool ≠ skin), evidence tiers for specific conditions, and routes to dermatology when skin disease is primary.

Stool panels sample the colon; skin microbiome tests (swabs) sample a different habitat entirely. Neither replaces clinical dermatology. See also sample-type limits for saliva vs stool vs blood.

That stool taxa cause or cure acne, eczema, or psoriasis; that skin and gut share one microbiome profile; that oral probiotics reliably colonise skin; or that eliminating one genus on a report fixes dermatology outcomes without topical or prescribed care.

Related on this site: Human Microbiome Project Consortium, 2012, Nature , Rinninella et al., 2019, Microorganisms